Latest news
Expion Health announced that its ExpionIQ platform has won the 2026 CIO 100 Award, presented by CIO magazine, a Foundry publication, to recognize organizations excelling in digital transformation and modernization. This marks the second time Expion Health has received this award, having previously won in 2024 for ExpionIQ Advisor.
On August 26, 2026, Longitude Health announced that its five member health systems—Michigan Medicine, Novant Health, Baylor Scott & White Health, Memorial Hermann Health System, and Providence—will jointly serve as design and development partners for Longitude Cell and Gene Therapy (Longitude CGT), helping to build a more efficient and scalable delivery model for advanced therapies.
On June 16, 2026, the Vive Bien/Live Well app became available to older adults in New Mexico, marking the first statewide adoption of the WHO's Integrated Care for Older People (ICOPE) framework in the US. Led by UNM Health Sciences Center and the New Mexico Health Care Authority, with ScienceSoft as technology partner, the app offers free, prevention-focused self-checks in eight health domains, available in English and Spanish, with offline support. A launch event was held on July 28, 2026, in Albuquerque.
CMS released first-half 2025 independent dispute resolution (IDR) data: case submissions approached 1.2 million, up about 40% year-over-year, with arbitration entities processing over 1.3 million cases. However, about 20% of cases were non-compliant, and a few private equity-backed suppliers dominated disputes, raising concerns about abuse.
On August 27, 2026, The Advocate: Supporting the Patient Voice released its 2026 U.S. Patient Advocacy Report. The report shows that Johnson & Johnson Innovative Medicine ranks first in patient advocacy for the eighth consecutive year, with AbbVie, Sanofi, and Novartis improving in four of the five benchmark categories, and Merck rising in three categories. Based on feedback from patient advocacy organizations and professional associations, the report aims to help the pharmaceutical industry collaborate better to improve patient care.
Healthcare systems are accelerating the adoption of artificial intelligence, but how to measure return on investment remains unclear. At the HLTH 2025 conference, experts discussed the complexity of financial returns and suggested evaluating AI value by combining metrics such as time savings, staff retention, and patient satisfaction.
ACTO announces its attainment of Veeva Gold Product Partner status, a certification based on its nearly decade-long partnership with Veeva, aimed at improving field team effectiveness, compliance, and customer engagement in the pharmaceutical and biotechnology industries.
CMS established a new Office of Health Technology and Products this week to centralize the agency's health technology strategy, covering the design and development of digital health tools, AI deployment, and advancement of healthcare data exchange. The office is led by Amy Gleason and comprises eight groups, including a department responsible for interoperability standards and policies. This move continues the Trump administration's emphasis on health technology and aligns with the Health Tech Ecosystem initiative launched in 2025.
On September 2, 2026, Corazon announced that it had completed a national executive search to successfully recruit a Chief Strategy and Business Development Officer for a large physician-led multispecialty clinic in the southeastern United States. The role will focus on strategic planning, market expansion, and operational performance improvement for the cardiovascular service line.
